4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-041303
10% owner acquired 464,285 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Section 32 Fund 2, LP 10% owner | 2019-07-22 | Conversion | +464,285 | 464,285 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Section 32 Fund 2, LP 10% owner | 2019-07-22 | Conversion · Series B Preferred Stock | −3,250,000 | 0 | D: show line 2 in the form |
Loading xslF345X03/a4.xml…